medicine

Bio & Pharma Celltrion unveils cancer medicine to expand new drug pipelines

South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...

Bio & Pharma Chong Kun Dang to build new plant for foray into biologics market

Chong Kun Dang Pharmaceutical Corp. is discussing building a research center and a plant in Siheung, about 30 kilometers southwest of Seoul, with th...

Bio & Pharma Yuhan’s lung cancer drug clears FDA hurdle for global debut

A new lung cancer treatment developed by South Korea’s Yuhan Corp. has secured approval from the US Food and Drug Administration (FDA) as a co...

Healthcare Korea’s booming medical tourism: Skin care, plastic surgery in demand

The number of foreign patients visiting South Korea for medical tourism hit a record high last year, driven by those who traveled to Korea for skin ...

Bio & Pharma Daewoong gets stem cell facility license in Indonesia

South Korea's Daewoong Pharmaceutical announced on Tuesday that its subsidiary Daewoong Biologics Indonesia has obtained a stem cell Lab Operational...

Mergers & Acquisitions Celltrion to sell portfolio of Takeda drugs to CBC Group

South Korea’s Celltrion Inc. will divest of a portfolio of Takeda Pharmaceutical's prescription medicines sold in Asia to CBC Group, a Singapo...

Bio & Pharma Samsung Bioepis gets FDA OK for its interchangeable biosimilar

Byooviz, a biosimilar of the macular degeneration treatment Lucentis and made by South Korea’s Samsung Bioepis, has received official design...

Bio & Pharma Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved

South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...

Bio & Pharma Daewoong Pharma's GER drug gets product OK from Mexico

South Korea’s Daewoong Pharmaceutical on Wednesday said its gastroesophageal reflux (GER) disease drug Fexuclue (active ingredient fexuprazan ...

Korean food Gluten-free Korean snack, pea soy sauce lure European gourmets

COLOGNE, Germany – The traditional Korean snack yakgwa and a soy-like sauce made with peas were named innovative foods of the year at the worl...

Bio & Pharma Genome & Co.’s bile duct cancer drug candidate enters Phase 2 trials

Genome & Company, a South Korean developer of microbiome-based drugs, on Tuesday said its GEN-001, a leading immunotherapy drug candidate for bi...

Bio & Pharma Moderna signs mRNA access deals with S.Korea's universities

The US biotech and pharmaceutical company Moderna on Friday announced signings of contracts with the academic-industry cooperation foundations of Ko...

Bio & Pharma Celltrion’s Vegzelma listed on prescription of 10 private US insurers

South Korea’s Celltrion Healthcare Co. announced on Wednesday that it has signed contracts with 10 insurance providers in the US to boost the ...

Bio & Pharma SK Bioscience buys 6.5 million Novavax shares for $83.4 million

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, said on Wednesday it has signed a deal to buy 6.5 million shares in US vacc...

Logistics CJ Logistics to enter global pharmaceutical transportation market

South Korea’s CJ Logistics on Wednesday said it obtained the certification CEIV Pharma, or the Center of Excellence for Independent Validators...

Bio & Pharma SK Biopharmaceuticals gets OK to sell epilepsy drug in Canada

South Korea's SK Biopharmaceuticals has received approval in Canada to sell its new epilepsy drug Cenobamate under the product name Xcopri. Having e...

Mergers & Acquisitions Blackstone seeks medicine distributor sale for 1st Korea exit

Blackstone Inc. has embarked on the process of selling South Korea’s largest medicine wholesaler Geo-Young Corp., a deal estimated at up to $1...

Bio & Pharma Samsung Biologics wins $897 mn in two deals with Pfizer

Samsung Biologics Co., the world’s largest contract manufacturing organization (CMO) in terms of production capacity, said on Tuesday it has w...

Bio & Pharma Celltrion applies for approval in US for eye treatment biosimilar

South Korean biopharmaceutical company Celltrion Inc. on Friday said it applied for approval from the US Food and Drug Administration (FDA) for CT-P...

Bio & Pharma S.Korea's Osteonic starts sports medicine exports to Japan

South Korea's surgical and medical instruments maker Osteonic Co. on Thursday announced the start of exports of its Kinex sports medicine products t...

Bio & Pharma S.Korea's Kainos Medicine exports AIDS treatment technology to China

South Korean new drug developer Kainos Medicine Inc. announced on Friday that it had signed a technology transfer agreement with Chinese pharmaceuti...

Bio & Pharma Celltrion Healthcare enters top 10 in hospital prescriptions in Turkey

South Korean biopharmaceutical company Celltrion Healthcare Co. on Thursday said it ranked in the top 10 out of 400 companies last year on the Turki...

Bio & Pharma S.Korea's Celltrion Healthcare launches Vegzelma in US

South Korea's Celltrion Healthcare Co. on Monday said it launched on the US market Vegzelma, a biosimilar of Bevacizumab, a medication for colorecta...

Bio & Pharma Kobiolabs, Kakao Healthcare to explore microbiome-based precision medicine solutions

Kobiolabs Co., South Korea's new drug development company for microbiomes, announced on Tuesday that it has signed a memorandum of understanding for...

Bio & Pharma CGBio inks export deal for hyaluronic acid fillers with Chinese distributor

CGBio, a South Korean bio-regenerative medical company, has signed an export deal with Shanghai Feiting Trading Co., a Chinese medical device distri...

Bio & Pharma Boryung, Axiom Space to set up JV to explore space healthcare options

South Korea's Boryung Corp., just decades ago a mom-and-pop pharmacy, will bring its healthcare expertise to space with Axiom Space Inc., a US comme...

Bio & Pharma LG Chem mulls shuttering in-vitro diagnostics business

LG Chem Ltd. is considering an exit from the in-vitro diagnostics market to focus more on novel drug development as it lagged its smaller local riva...

Bio & Pharma Novel medicines poised to be Korea’s next mainstay export

South Korea, a major global generic and biosimilar medicine producer with leading names such as Samsung Biologics Co. and Celltrion Inc., has rapidl...

Bio & Pharma Korea United Pharm signs contract to supply medicines to Saudi Arabia

Korea United Pharm. Inc. announced on Monday that it signed a contract to supply nine types of medicines, including 11 anticancer drugs, to Saudi ph...

Bio & Pharma Ybrain, Chong Kun Dang join forces for digital medicine distribution

South Korean electroceutical platform company Ybrain Inc. said on Tuesday it has entered into a joint promotion agreement with Chong Kun Dang Pharma...